Placebo News and Research

RSS

FDA approves new drug for treatment of rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

29 Nov 2018

New ointment for treating brown recluse spider bites is tested on humans

The bite from a brown recluse spider (Loxosceles) can cause skin necrosis, renal failure, and even death. A new ointment is being tested in Brazil, however. Its effects have already been proven in tests conducted in cell cultures and animal models.

29 Nov 2018

New antibody can reduce swelling attacks in patients with hereditary angioedema

Patients with hereditary angioedema experience recurrent and sometimes life-threatening swelling attacks. Researchers from Charité - Universitätsmedizin Berlin have tested an antibody capable of reducing the frequency of these swelling attacks by more than 90 percent.

28 Nov 2018

Botulinum toxin injections show promise to suppress postoperative atrial fibrillation

Postoperative atrial fibrillation is a common complication, affecting one quarter to one half of all patients following cardiac surgery.

28 Nov 2018

Prebiotic supplement may be effective alternative to reduce GI disturbances in autistic children

Diets free from gluten and casein are often recommended as a way to reduce gastrointestinal (GI) problems in children with autistic spectrum disorders.

22 Nov 2018

MDMA could help gain trust but does not make one naive find researchers

MDMA or ecstasy pills can help individuals trust more and cooperate say a team of researchers who are looking at its properties that could help treat psychological disorders. The study was published this week in the latest issue of the Journal of Neuroscience.

21 Nov 2018

Peanut allergies could soon have a drug treatment

Millions of individuals worldwide suffer from peanut allergies. Researchers are developing a new treatment for fighting this allergy. A clinical trial had been conducted and the results are in.

20 Nov 2018

First modeling system developed for testing age-specific human immune responses to vaccines

A team of scientists at Boston Children's Hospital has developed the first modeling system for testing age-specific human immune responses to vaccines -- outside the body. The practical, cost-effective new platform, using all human components, is expected to accelerate and de-risk the development, assessment and selection of vaccines.

20 Nov 2018

Purified omega-3 and aspirin reduce pre-cancerous bowel polyps, shows study

Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according to new research.

20 Nov 2018

New drug shows promise for treating people with peanut allergy

Controlled ingestion of peanut protein could help build tolerance in peanut allergy sufferers. Authors of a new study published in the New England Journal of Medicine say an oral immunotherapy drug they tested could be the first FDA-approved medication of its kind for people with peanut allergy.

19 Nov 2018

Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia

Nightmares and insomnia often accompany posttraumatic stress disorder and increase suicide risk.

19 Nov 2018

Recreational drug may help people regain trust in others

The recreational drug known as ecstasy or molly may help people regain trust in others after being betrayed, suggests results of a controlled laboratory study, published in JNeurosci, of healthy men given a pure form of the substance.

From Society for Neuroscience 19 Nov 2018

FDA approves antibacterial drug to treat travelers' diarrhea

The U.S. Food and Drug Administration today approved Aemcolo (rifamycin), an antibacterial drug indicated for the treatment of adult patients with travelers' diarrhea caused by noninvasive strains of Escherichia coli (E. coli), not complicated by fever or blood in the stool.

17 Nov 2018

New artificial intelligence-based method predicts treatment effectiveness

How can a doctor predict the treatment outcome of an individual patient? Traditionally, the effectiveness of medical treatments is studied by randomized trials where patients are randomly divided into two groups: one of the groups is given treatment, and the other a placebo.

16 Nov 2018

Angiotensin receptor blockers improve sodium excretion in blacks

Drugs that inhibit a hormone that constricts blood vessels also help improve sodium excretion in blacks who hold onto too much sodium in the face of stress, investigators report.

13 Nov 2018

Fish oil or omega 3 fatty acid supplements can prevent heart attacks finds study

A couple of clinical trials from Harvard researchers have shown that regular consumption of fish or fish oil supplements can reduce the risk of getting heart attacks significantly.

13 Nov 2018

Diabetes medication reduces risk of heart failure hospitalization

In the largest trial to date to assess cardiovascular outcomes for an important class of diabetes medications, researchers have found that dapagliflozin markedly reduced the risk of hospitalization for heart failure in a broad population of patients with diabetes.

12 Nov 2018

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

When it comes to reducing inflammation to decrease the risk of heart disease and stroke, results from the much-anticipated Cardiovascular Inflammation Reduction Trial indicate that targeting the right inflammatory pathways in at-risk patients is crucial.

12 Nov 2018

Hypertonic saline shown to aid breathing in cystic fibrosis babies

The first-ever randomized controlled trial on babies with CF has found that treatment with inhaled hypertonic saline can improve breathing and lung health.

9 Nov 2018

Targeting one brain region with alternating current could decrease symptoms of chronic pain

For the first time, researchers at the UNC School of Medicine showed they could target one brain region with a weak alternating current of electricity, enhance the naturally occurring brain rhythms of that region, and significantly decrease symptoms associated with chronic lower back pain.

9 Nov 2018

Placebo News and Research

FDA approves new drug for treatment of rare autoimmune disorder

New ointment for treating brown recluse spider bites is tested on humans

New antibody can reduce swelling attacks in patients with hereditary angioedema

Botulinum toxin injections show promise to suppress postoperative atrial fibrillation

Prebiotic supplement may be effective alternative to reduce GI disturbances in autistic children

MDMA could help gain trust but does not make one naive find researchers

Peanut allergies could soon have a drug treatment

First modeling system developed for testing age-specific human immune responses to vaccines

Purified omega-3 and aspirin reduce pre-cancerous bowel polyps, shows study

New drug shows promise for treating people with peanut allergy

Drug used to treat PTSD does not reduce suicidal thinking, may worsen nightmares and insomnia

Recreational drug may help people regain trust in others

FDA approves antibacterial drug to treat travelers' diarrhea

New artificial intelligence-based method predicts treatment effectiveness

Angiotensin receptor blockers improve sodium excretion in blacks

Fish oil or omega 3 fatty acid supplements can prevent heart attacks finds study

Diabetes medication reduces risk of heart failure hospitalization

Inexpensive and effective drug does not reduce major adverse cardiovascular event rates

Hypertonic saline shown to aid breathing in cystic fibrosis babies

Targeting one brain region with alternating current could decrease symptoms of chronic pain

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News